search
Back to results

Passive Training as a Treatment for Diabetic Foot Ulcers

Primary Purpose

Diabetic Foot Ulcers

Status
Terminated
Phase
Not Applicable
Locations
Denmark
Study Type
Interventional
Intervention
Passive knee extensor machine
Sponsored by
Herlev Hospital
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional prevention trial for Diabetic Foot Ulcers

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  1. Informed consent obtained before any trial-related activities. Trial-related activities are any procedures that are carried out as part of the trial, including activities to determine suitability for the trial.
  2. Diabetes mellitus according to the World Health Organisation (WHO) criteria (see http://www.who.int/diabetes/publications/en/ ) and a stable treatment treated in a period of 14 days prior to screening with insulin or an oral antidiabetic agent. Stable is defined as stable HBA1c.

4. Foot ulcer: size: diameter > 1cm. Duration of wound > 6 weeks Location: Full thickness skin defect distal to the malleoli.

5. Male or female, age >18 years at the time of signing informed consent. 6. Non-dementia diagnosis.

Exclusion Criteria:

  1. Major infection; acute cellulitis, osteomyelitis or gangrene anywhere in the affected extremity.
  2. Malignant disease
  3. Major traumatic tissue damage.
  4. Major lower extremity amputation.

Sites / Locations

  • Herlev Hospital

Arms of the Study

Arm 1

Arm 2

Arm Type

No Intervention

Experimental

Arm Label

Control group

Passive training group

Arm Description

A control group receiving standard wound treatment consisting of debridement, dressings, compression, offloading footwear and if necessary antibiotics.

An Intervention group doing passive exercise for 8 weeks in knee extensor machine, and receiving standard wound treatment consisting of debridement, dressings, compression, offloading footwear and if necessary antibiotics.

Outcomes

Primary Outcome Measures

Wound healing change quantified by digital photo planimetry
The digital photo planimetry measurements are compared to the baseline measurement at week 0
The change in Wagner's wound classification.
measurements at baseline are compared to week 8
The change in Wagner's wound classification.
The measurements at week 3, 5 and 16 are compared to the baseline week 0 and 8
Wound healing change quantified by digital photo planimetry
The measurements at week 3, 5 and 16 are compared to the baseline week 0 and 8

Secondary Outcome Measures

Perfusion of the lower extremity.
Quantified by measuring the blood flow in arteria femoralis (doppler)
Distal blood pressure measurement.
Includes skin perfusion test
The biochemical changes during wound healing, is assessed by biochemical markers in peripheral venous blood samples.
Hemoglobin mmol/L
Histological changes of the muscle tissue.
Analysed from muscle biopsies
Histological changes of the tissue composition in the edge of the wound.
Analysed from wound edge biopsy
Angiogenetic factors analysed from muscle biopsy
• Total RNA isolated from the muscle biopsies, and the mRNA content of VEGF, eNOS, MMP-2, MMP-9, TIMP-1, TIMP-2, Tie-2, ANG-1, ANG-2 determined by PCR
Dexa Scanning of the lower limb.
To measure the tissue composition change
Dexa Scanning of the lower limb.
To measure the bone mineral density change
Patient related outcome measurements (PROM's)
Medical Outcome Study Short Form 36 (MOS SF36)
the change in 30 second chair stand test
the change in maximum leg extension test
Adverse events
Autonomic neuropathy
vagus device measurements at baseline and after 8 weeks
Distal blood pressure change measurement.
Arm, ankle and toe pressure. The ankle brachial index (ABI) is calculated from measuring the arm and ankle systolic blood pressure.
Autonomic neuropathy
sudoscan measurements at baseline and after 8 weeks
Patient related outcome measurements (PROM's)
the Euroqol five Dimensions questionnaire (EQ-5D)
Histological changes of the endothelial cells
analysed from muscle biopsies
Histological changes of the capillary density
Analysed from muscle biopsies
The biochemical changes during wound healing, is assessed by biochemical markers in peripheral venous blood samples.
Glycated HbA1c in mmol/mol
The biochemical changes during wound healing, is assessed by biochemical markers in peripheral venous blood samples.
Glucose in mmol/l
The biochemical changes during wound healing, is assessed by biochemical markers in peripheral venous blood samples.
C-reactive protein in mg/L
The biochemical changes during wound healing, is assessed by biochemical markers in peripheral venous blood samples.
leucocytes and differential count, in 10^9/L
The biochemical changes during wound healing, is assessed by biochemical markers in peripheral venous blood samples.
Thrombocytes in 10^9/L
The biochemical changes during wound healing, is assessed by biochemical markers in peripheral venous blood samples.
Sodium,mmol/L
The biochemical changes during wound healing, is assessed by biochemical markers in peripheral venous blood samples.
potassium in mmol/L
The biochemical changes during wound healing, is assessed by biochemical markers in peripheral venous blood samples.
eGlomerular filtration rate, mL/min/1,73 m^2
The biochemical changes during wound healing, is assessed by biochemical markers in peripheral venous blood samples.
Albumin g/L
The biochemical changes during wound healing, is assessed by biochemical markers in peripheral venous blood samples.
Creatinine, μmol/L
The biochemical changes during wound healing, is assessed by biochemical markers in peripheral venous blood samples.
Alanine Transaminase, U/L
The biochemical changes during wound healing, is assessed by biochemical markers in peripheral venous blood samples.
Basic Phosphatase, U/L
The biochemical changes during wound healing, is assessed by biochemical markers in peripheral venous blood samples.
YKL 40, μg/L

Full Information

First Posted
May 13, 2016
Last Updated
February 20, 2020
Sponsor
Herlev Hospital
Collaborators
University of Copenhagen
search

1. Study Identification

Unique Protocol Identification Number
NCT02785198
Brief Title
Passive Training as a Treatment for Diabetic Foot Ulcers
Official Title
Passive Training as a Treatment for Diabetic Foot Ulcers: A Randomized, Single-blinded Clinical Trial of Wound Healing
Study Type
Interventional

2. Study Status

Record Verification Date
February 2020
Overall Recruitment Status
Terminated
Why Stopped
due to finalizing af phd project and fundings
Study Start Date
April 2016 (Actual)
Primary Completion Date
June 2018 (Actual)
Study Completion Date
July 2018 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Herlev Hospital
Collaborators
University of Copenhagen

4. Oversight

Data Monitoring Committee
Yes

5. Study Description

Brief Summary
Overall project design: This PhD project involves a randomized study on diabetic individuals with healing resistant wounds, comparing the effect of passive movement of the lower limb with standard treatment of diabetic wounds. How to effectively improve the condition of peripheral arterial disease is limited. The primary purpose of this study is to uncover whether passive movement of the lower limb will influence muscle oxygen demand and thereby increasing blood flow. An increase in muscle oxygen demand is likely to increase both blood flow rate and the number of capillaries, which would induce the healing of wounds, that were not previously possible. The secondary purpose is to increase understanding of the pathophysiological processes in wound healing through the study of biochemical markers of vascularization, inflammation and stem cell recruitment in blood samples. Further on analyzing the skin and muscle biopsies of the number and quality of endothelial cells and Capillary density and to develop new quantifiable methods to evaluate wound healing in. The project is a randomized trial, consisting of simple passive training to improve blood vessel function, increase the growth of the smallest blood vessels, thereby preventing ulceration and ultimately amputation.
Detailed Description
Background information Diabetic foot ulcers are one of the most frequent and serious complication in diabetes mellitus. Despite attempts of prophylaxis*, only two-thirds of the diabetic foot ulcers eventually heal, and up to 15-20% will ultimately require a minor or major amputation (Major lower extremity amputation is defined as through or above the ankle joint, and minor amputations is below the ankle joint. The incidence of diabetes is growing, but the multifactorial causes of impaired healing of chronic diabetic ulcers are still not well understood. The diabetic foot ulcers are known to reduce the quality of life for patients both psychically and psychologically and therefore further investigation in new treatment options is plausible. Current knowledge regarding how to improve the condition in the beginning phase of peripheral artery disease (PAD) is limited. Investigators know that high oxygen tension and perfusion of the limb as well as an adequate density of microvessels in the tissue, is essential to wound healing. Therefore, interventions that increase blood flow and promote microcirculatory growth are likely to be beneficial in the treatment of wound healing. *Dressings, debridement, compression, clinical observation, antibiotics and glycemic control It has been reported that passive training consisting of knee flexion/extension in a kinetic machine has a beneficial effect on up regulation of growth factors, remicrovascularization and improved blood flow. Høier et al described that passive movement of the leg induced a two-fold elevation in blood flow, elevation of angiogenic factors and initiates capillarization in skeletal muscle. All three factors are often impaired in the diabetic leg, which results in poor wound healing. Due to the typical localization of the diabetic foot ulcers, this patient group is unable to exercise properly. Therefore will the investigators use a recent innovative model for the improvement of the limb microcirculation, developed at the Department of Nutrition, Exercise and Sports, University of Copenhagen, involving passive movement of the lower leg, for inducing increased blood flow and microcirculatory growth. Rationale for the trial Diabetic patients have impaired wound healing due to multifactorial causes. The investigators know that high oxygen tension, and perfusion is essential to wound healing, and according to Høier et al's study, passive training can increase the perfusion and elevate proangiogenic factors in both young healthy males and peripheral artery disease (PAD) patients. Null hypothesis: Passive training does not lead to enhanced healing of diabetic foot ulcers. Passive training of the lower limb does not affect perfusion of the trained limb. Perspective: This projects aim is to discover that passive training of the lower limb will increase the healing in diabetic foot ulcers. In addition, present a new treatment offer to diabetic patients with ulcers, who are not able to heal properly or perform active exercises. The investigators hope to see that the benefits of training and accelerated healing affect the PROM's. Further on to present new knowledge of the specific molecular and functional changes that occur in the tissue during wound healing. This knowledge will be very important to improve our understanding of why ulcerations occur and why the tissue begins to decompose. This is a prospective, randomized, single-blinded, parallel controlled design trial in subjects with diabetes mellitus investigating passive training as a treatment for the diabetic ulcer. The participants are randomized to either a control group or intervention. The control group receiving standard wound treatment, and an intervention group receiving standard wound treatment, and passive training exercises for 8 weeks. The participants will be followed for 16 weeks or until clinical wound healing. All participants will receive standard wound care consisting of debridement, dressings, compression, offloading footwear and if necessary antibiotics The comparison groups should be as similar as possible as regard to important participant characteristics that might influence the response to the intervention. Therefore, a block randomization to ensure that equal numbers of participants with a characteristic thought to affect prognosis or response to the intervention, will be allocated to each comparison group.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Diabetic Foot Ulcers

7. Study Design

Primary Purpose
Prevention
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
Outcomes Assessor
Allocation
Randomized
Enrollment
21 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Control group
Arm Type
No Intervention
Arm Description
A control group receiving standard wound treatment consisting of debridement, dressings, compression, offloading footwear and if necessary antibiotics.
Arm Title
Passive training group
Arm Type
Experimental
Arm Description
An Intervention group doing passive exercise for 8 weeks in knee extensor machine, and receiving standard wound treatment consisting of debridement, dressings, compression, offloading footwear and if necessary antibiotics.
Intervention Type
Device
Intervention Name(s)
Passive knee extensor machine
Intervention Description
The passive training machine, moves both legs from flexion to extension and back, 60 times per minute in 1 hour, 3 times per week. ROM is 60 degrees
Primary Outcome Measure Information:
Title
Wound healing change quantified by digital photo planimetry
Description
The digital photo planimetry measurements are compared to the baseline measurement at week 0
Time Frame
Photos are taken at week 0 and 8
Title
The change in Wagner's wound classification.
Description
measurements at baseline are compared to week 8
Time Frame
week 0 and 8
Title
The change in Wagner's wound classification.
Description
The measurements at week 3, 5 and 16 are compared to the baseline week 0 and 8
Time Frame
week 3, 5 and 16
Title
Wound healing change quantified by digital photo planimetry
Description
The measurements at week 3, 5 and 16 are compared to the baseline week 0 and 8
Time Frame
week 3, 5 and 16
Secondary Outcome Measure Information:
Title
Perfusion of the lower extremity.
Description
Quantified by measuring the blood flow in arteria femoralis (doppler)
Time Frame
week 0, 3, 5, 8 and 16.
Title
Distal blood pressure measurement.
Description
Includes skin perfusion test
Time Frame
week 0 and 8.
Title
The biochemical changes during wound healing, is assessed by biochemical markers in peripheral venous blood samples.
Description
Hemoglobin mmol/L
Time Frame
Week 0, 5 and 8
Title
Histological changes of the muscle tissue.
Description
Analysed from muscle biopsies
Time Frame
Week 0,5 and 8
Title
Histological changes of the tissue composition in the edge of the wound.
Description
Analysed from wound edge biopsy
Time Frame
Week 0,5 and 8
Title
Angiogenetic factors analysed from muscle biopsy
Description
• Total RNA isolated from the muscle biopsies, and the mRNA content of VEGF, eNOS, MMP-2, MMP-9, TIMP-1, TIMP-2, Tie-2, ANG-1, ANG-2 determined by PCR
Time Frame
Week 0,5 and 8
Title
Dexa Scanning of the lower limb.
Description
To measure the tissue composition change
Time Frame
Week 0 and 8
Title
Dexa Scanning of the lower limb.
Description
To measure the bone mineral density change
Time Frame
Week 0 and 8
Title
Patient related outcome measurements (PROM's)
Description
Medical Outcome Study Short Form 36 (MOS SF36)
Time Frame
Week 0, 8 and 16
Title
the change in 30 second chair stand test
Time Frame
Week 0 and 8
Title
the change in maximum leg extension test
Time Frame
Week 0 and 8
Title
Adverse events
Time Frame
Week 0, 3, 5, 8 and 16
Title
Autonomic neuropathy
Description
vagus device measurements at baseline and after 8 weeks
Time Frame
Week 0 and 8
Title
Distal blood pressure change measurement.
Description
Arm, ankle and toe pressure. The ankle brachial index (ABI) is calculated from measuring the arm and ankle systolic blood pressure.
Time Frame
week 0 and 8
Title
Autonomic neuropathy
Description
sudoscan measurements at baseline and after 8 weeks
Time Frame
Week 0 and 8
Title
Patient related outcome measurements (PROM's)
Description
the Euroqol five Dimensions questionnaire (EQ-5D)
Time Frame
Week 0, 8 and 16
Title
Histological changes of the endothelial cells
Description
analysed from muscle biopsies
Time Frame
0,5 and 8
Title
Histological changes of the capillary density
Description
Analysed from muscle biopsies
Time Frame
0,5 and 8
Title
The biochemical changes during wound healing, is assessed by biochemical markers in peripheral venous blood samples.
Description
Glycated HbA1c in mmol/mol
Time Frame
Week 0, 5 and 8
Title
The biochemical changes during wound healing, is assessed by biochemical markers in peripheral venous blood samples.
Description
Glucose in mmol/l
Time Frame
Week 0, 5 and 8
Title
The biochemical changes during wound healing, is assessed by biochemical markers in peripheral venous blood samples.
Description
C-reactive protein in mg/L
Time Frame
Week 0, 5 and 8
Title
The biochemical changes during wound healing, is assessed by biochemical markers in peripheral venous blood samples.
Description
leucocytes and differential count, in 10^9/L
Time Frame
Week 0, 5 and 8
Title
The biochemical changes during wound healing, is assessed by biochemical markers in peripheral venous blood samples.
Description
Thrombocytes in 10^9/L
Time Frame
Week 0, 5 and 8
Title
The biochemical changes during wound healing, is assessed by biochemical markers in peripheral venous blood samples.
Description
Sodium,mmol/L
Time Frame
Week 0, 5 and 8
Title
The biochemical changes during wound healing, is assessed by biochemical markers in peripheral venous blood samples.
Description
potassium in mmol/L
Time Frame
Week 0, 5 and 8
Title
The biochemical changes during wound healing, is assessed by biochemical markers in peripheral venous blood samples.
Description
eGlomerular filtration rate, mL/min/1,73 m^2
Time Frame
Week 0, 5 and 8
Title
The biochemical changes during wound healing, is assessed by biochemical markers in peripheral venous blood samples.
Description
Albumin g/L
Time Frame
Week 0, 5 and 8
Title
The biochemical changes during wound healing, is assessed by biochemical markers in peripheral venous blood samples.
Description
Creatinine, μmol/L
Time Frame
Week 0, 5 and 8
Title
The biochemical changes during wound healing, is assessed by biochemical markers in peripheral venous blood samples.
Description
Alanine Transaminase, U/L
Time Frame
Week 0, 5 and 8
Title
The biochemical changes during wound healing, is assessed by biochemical markers in peripheral venous blood samples.
Description
Basic Phosphatase, U/L
Time Frame
Week 0, 5 and 8
Title
The biochemical changes during wound healing, is assessed by biochemical markers in peripheral venous blood samples.
Description
YKL 40, μg/L
Time Frame
Week 0, 5 and 8

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Informed consent obtained before any trial-related activities. Trial-related activities are any procedures that are carried out as part of the trial, including activities to determine suitability for the trial. Diabetes mellitus according to the World Health Organisation (WHO) criteria (see http://www.who.int/diabetes/publications/en/ ) and a stable treatment treated in a period of 14 days prior to screening with insulin or an oral antidiabetic agent. Stable is defined as stable HBA1c. 4. Foot ulcer: size: diameter > 1cm. Duration of wound > 6 weeks Location: Full thickness skin defect distal to the malleoli. 5. Male or female, age >18 years at the time of signing informed consent. 6. Non-dementia diagnosis. Exclusion Criteria: Major infection; acute cellulitis, osteomyelitis or gangrene anywhere in the affected extremity. Malignant disease Major traumatic tissue damage. Major lower extremity amputation.
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Tue Smith Joergensen, MD
Organizational Affiliation
Herlev and Gentofte Hospital, The Department of Orthopedics
Official's Role
Principal Investigator
Facility Information:
Facility Name
Herlev Hospital
City
Herlev
State/Province
Capital Region Of Denmark
ZIP/Postal Code
2730
Country
Denmark

12. IPD Sharing Statement

Plan to Share IPD
No
Citations:
PubMed Identifier
21388445
Citation
Moxey PW, Gogalniceanu P, Hinchliffe RJ, Loftus IM, Jones KJ, Thompson MM, Holt PJ. Lower extremity amputations--a review of global variability in incidence. Diabet Med. 2011 Oct;28(10):1144-53. doi: 10.1111/j.1464-5491.2011.03279.x.
Results Reference
background
PubMed Identifier
11147390
Citation
Tennvall GR, Apelqvist J, Eneroth M. Costs of deep foot infections in patients with diabetes mellitus. Pharmacoeconomics. 2000 Sep;18(3):225-38. doi: 10.2165/00019053-200018030-00003.
Results Reference
background
PubMed Identifier
25069580
Citation
Baltzis D, Eleftheriadou I, Veves A. Pathogenesis and treatment of impaired wound healing in diabetes mellitus: new insights. Adv Ther. 2014 Aug;31(8):817-36. doi: 10.1007/s12325-014-0140-x. Epub 2014 Jul 29.
Results Reference
background
PubMed Identifier
18442185
Citation
Hinchliffe RJ, Valk GD, Apelqvist J, Armstrong DG, Bakker K, Game FL, Hartemann-Heurtier A, Londahl M, Price PE, van Houtum WH, Jeffcoate WJ. A systematic review of the effectiveness of interventions to enhance the healing of chronic ulcers of the foot in diabetes. Diabetes Metab Res Rev. 2008 May-Jun;24 Suppl 1:S119-44. doi: 10.1002/dmrr.825.
Results Reference
background
PubMed Identifier
18442179
Citation
Gary Sibbald R, Woo KY. The biology of chronic foot ulcers in persons with diabetes. Diabetes Metab Res Rev. 2008 May-Jun;24 Suppl 1:S25-30. doi: 10.1002/dmrr.847.
Results Reference
background
PubMed Identifier
24111834
Citation
Jorgensen ME, Almdal TP, Faerch K. Reduced incidence of lower-extremity amputations in a Danish diabetes population from 2000 to 2011. Diabet Med. 2014 Apr;31(4):443-7. doi: 10.1111/dme.12320. Epub 2013 Oct 21.
Results Reference
background
PubMed Identifier
24406089
Citation
Vogel TR, Petroski GF, Kruse RL. Impact of amputation level and comorbidities on functional status of nursing home residents after lower extremity amputation. J Vasc Surg. 2014 May;59(5):1323-30.e1. doi: 10.1016/j.jvs.2013.11.076. Epub 2014 Jan 7.
Results Reference
background
PubMed Identifier
24766143
Citation
McDonald S, Sharpe L, Blaszczynski A. The psychosocial impact associated with diabetes-related amputation. Diabet Med. 2014 Nov;31(11):1424-30. doi: 10.1111/dme.12474. Epub 2014 May 24.
Results Reference
background
PubMed Identifier
12737879
Citation
Jeffcoate WJ, Harding KG. Diabetic foot ulcers. Lancet. 2003 May 3;361(9368):1545-51. doi: 10.1016/S0140-6736(03)13169-8.
Results Reference
background
PubMed Identifier
24761347
Citation
Pence BD, Woods JA. Exercise, Obesity, and Cutaneous Wound Healing: Evidence from Rodent and Human Studies. Adv Wound Care (New Rochelle). 2014 Jan 1;3(1):71-79. doi: 10.1089/wound.2012.0377.
Results Reference
background
PubMed Identifier
26590707
Citation
Rasmussen BSB, Yderstraede KB, Carstensen B, Skov O, Beck-Nielsen H. Substantial reduction in the number of amputations among patients with diabetes: a cohort study over 16 years. Diabetologia. 2016 Jan;59(1):121-129. doi: 10.1007/s00125-015-3781-7. Epub 2015 Nov 22.
Results Reference
background
PubMed Identifier
18094062
Citation
Hellsten Y, Rufener N, Nielsen JJ, Hoier B, Krustrup P, Bangsbo J. Passive leg movement enhances interstitial VEGF protein, endothelial cell proliferation, and eNOS mRNA content in human skeletal muscle. Am J Physiol Regul Integr Comp Physiol. 2008 Mar;294(3):R975-82. doi: 10.1152/ajpregu.00677.2007. Epub 2007 Dec 19.
Results Reference
background
PubMed Identifier
20693292
Citation
Hoier B, Rufener N, Bojsen-Moller J, Bangsbo J, Hellsten Y. The effect of passive movement training on angiogenic factors and capillary growth in human skeletal muscle. J Physiol. 2010 Oct 1;588(Pt 19):3833-45. doi: 10.1113/jphysiol.2010.190439.
Results Reference
background

Learn more about this trial

Passive Training as a Treatment for Diabetic Foot Ulcers

We'll reach out to this number within 24 hrs